SCHEMBL23577603

SCHEMBL23577603

COC(=O)c1cc2c(cc1[N+](=O)[O-])OCC(=O)N2C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.45
▸ POLB P06746 4/20 0.45
▸ KDM4E B2RXH2 3/20 0.45
▸ RECQL P46063 3/20 0.45
▸ TDP1 Q9NUW8 3/20 0.45
▸ GAA P10253 2/20 0.45
▸ NR4A1 P22736 1/20 0.45
▸ SIRT6 Q8N6T7 1/20 0.45
▸ ALDH1A1 P00352 6/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ PDGFRB P09619 1/20 0.37
▸ FGFR1 P11362 1/20 0.37
▸ PDGFRA P16234 1/20 0.37
▸ FLT1 P17948 1/20 0.37
▸ FGFR3 P22607 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ HTT P42858 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29010945 0.95 SIRT6 (0.45) MAPTPOLBKDM4ERECQLTDP1
SCHEMBL30183714 0.85 ALDH1A1 (0.43) MAPTPOLBKDM4ERECQLTDP1
SCHEMBL23590845 0.85 ALDH1A1 (0.43) MAPTPOLBKDM4ERECQLTDP1
SCHEMBL29267734 0.85 TSHR (0.44) MAPTPOLBKDM4ERECQLTDP1
SCHEMBL30183974 0.82 KDM4E (0.39) MAPTPOLBKDM4ERECQLTDP1
SCHEMBL25387167 0.82 CTRC (0.38) MAPTPOLBKDM4ERECQLTDP1
SCHEMBL23578383 0.80 KDM4E (0.56) MAPTPOLBKDM4EGAAALDH1A1
SCHEMBL24885330 0.80 KDM4E (0.40) POLBKDM4EALDH1A1MEN1KMT2A
SCHEMBL24885326 0.80 PDE3B (0.39) MAPTPOLBKDM4EGAAALDH1A1
SCHEMBL30034996 0.80 KDM4E (0.56) MAPTPOLBKDM4EGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081521-B1 SUBSTITUTED TRICYCLIC COMPOUNDS LUPIN LTD (IN) 2025-12-10 — — EP disclosed
CN-115605476-B Substituted tricyclic compounds 鲁宾有限公司 2024-05-24 — — CN disclosed
WO-2023165438-A1 TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF 浙江海正药业股份有限公司 2023-09-07 — — WO disclosed
US-20230119316-A1 Substituted Tricyclic Compounds LUPIN LIMITED (IN) 2023-04-20 — — US disclosed
CN-115605476-A Substituted tricyclic compounds 鲁宾有限公司(IN) 2023-01-13 — — CN disclosed
EP-4081521-A1 SUBSTITUTED TRICYCLIC COMPOUNDS Lupin Limited (IN) 2022-11-02 — — EP disclosed
WO-2021130731-A1 SUBSTITUTED TRICYCLIC COMPOUNDS LUPIN LIMITED (IN) 2021-07-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230119316-A1 Substituted Tricyclic Compounds SOS1, RSU1, KSR1 MAPT 157/4885POLB 1789/4885KDM4E 4661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback